Table 1. Proposed mechanisms of statin effects.
Inflammation in thrombosis |
IL-6 (19) |
IL-8 (19) |
P-selectin (18) |
MCP-1 (18) |
TNF-alpha (21) |
CRP (19) |
D-dimer |
Statins and biomarkers |
IL-6 (31) |
IL-8 (31) |
P-selectin (38) |
MCP-1 (31) |
CRP (32) |
eNOS |
Thrombomodulin (55) |
Apolipoprotein A1 |
D-dimer |
PAI-1 (37) |
TF (42) |
MPO (42) |
Statin antiplatelet effects |
Redox signaling interference (44) |
NADPH oxidase downregulation (45) |
Thromboxane A2 Inhibition (45) |
Peroxisome proliferator activated receptors (40) |
Decreased macrophage infiltration (42) |
Vein wall scarring (42) |
Inhibition of mevalonate pathway (48) |
Statins and microvesicles |
TF inhibition (18) |
Procoagulant microparticle inhibition (48) |
Factor V inhibition (48) |
Statins and clot structure |
Alterations of fibrin clot structure (41) |
Increased clot permeability (52) |
Increased susceptibility to lysis (52) |
Other |
Nets (42) |
Valve pocket sinus (18) |
IL-6, interleukin 6; IL-8, interleukin 8; MCP-1, monocyte chemotactic protein 1; TNF-alpha, tumor necrosis factor alpha; CRP, C-reactive protein; PAI-1, plasminogen activator inhibitor-1; TF, tissue factor; MPO, myeloperoxidase; Nets, neutrophil extracellular traps; eNOS, endothelial nitric oxide synthase.